Global survey presented at the Digital Liver Cancer Summit 202... - 05 February 2021 10:00

GENEVA, February 2, 2021, /PRNewswire-AsiaNet/-- Digital Liver Cancer Summit 2021: A global survey assessing the impact of COVID-19 on liver cancer has revealed delays in the screening, diagnosis, and treatment of the disease, with experts issuing stark warnings on liver cancer survival rates. ...

  NCCN Gets Personal About Improving Global Cancer Care for Worl... - 04 February 2021 08:05

PLYMOUTH MEETING, Pa., Feb. 4, 2021 /PRNewswire-AsiaNet/ -- - Nonprofit alliance behind gold standard oncology guidelines shares stories of personal connections to cancer that inspire many within the organization. - Global oncology community looks at the impact from COVID-19 on cancer care over the past...

  Eucure Biopharma Announces Encouraging Antitumor Activity of I... - 04 February 2021 02:45

BOSTON and BEIJING, Feb. 4, 2021 /PRNewswire/ -- Eucure Biopharma, a biopharmaceutical company dedicated to developing immuno-oncology antibody drugs, announced that its investigational anti-CD40 antibody drug (YH003), when combined with Junshi Biosciences' anti-PD-1 antibody Toripalimab (TUOYI(...

  Guardant360 CDx submitted for regulatory approval in Japan - 03 February 2021 21:41

TOKYO, Feb. 3, 2021 /PRNewswire-AsiaNet/ -- A comprehensive genomic profiling test utilizing blood samples from patients with advanced solid tumors Guardant Health Japan, an affiliate of Guardant Health Asia, Middle East & Africa (AMEA) has announced that it has submitted its applicati...

  Globally unique MRI Guarantee: The highest MRI safety with hea... - 02 February 2021 18:00

INNSBRUCK, Austria, Feb. 2, 2021 /PRNewswire-AsiaNet/ -- - Worry-free, safe magnetic resonance imaging (MRI) with MED-EL cochlear, middle ear or bone conduction implants – now with lifetime guarantee. For immediate access to an MRI examination without surgery, discomfort or hearing downtime. The inno...

  CF PharmTech and Chengdu Shangyi Launch the "Home-Based Recove... - 02 February 2021 12:00

SUZHOU, China, Feb. 2, 2021 /PRNewswire-Asianet/ -- CF PharmTech, Inc. is a fully integrated pharmaceutical company in China specializing in the treatment of respiratory diseases. Chengdu Shangyi Information Technology Co., Ltd is a professional IT service company in the healthcare industry in Chin...

  Fullerton Health Australia acquires WA-based corporate health ... - 02 February 2021 12:00

SINGAPORE, Feb. 2, 2021 /PRNewswire-Asianet/ -- Leading healthcare provider Fullerton Health has further strengthened its position in Australia with its recent acquisition of Western Australia (WA) based Capstone Health. Capstone Health provides specialist medical and emergency services to t...

  DW Healthcare Partners Invests in Parnell - 02 February 2021 12:00

PARK CITY, Utah, Feb. 2, 2021 /PRNewswire-AsiaNet/ -- DW Healthcare Partners ("DWHP") a healthcare-focused private equity firm, announced the completion of its investment in Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF) ("Parnell" or the "Company"). Founded over 50 years ago in Australia, Parnell...

  MedTech Startup See-Mode Technologies Announces CE Mark and Au... - 02 February 2021 09:00

SINGAPORE and MELBOURNE, Australia, Feb. 2, 2021 /PRNewswire-AsiaNet/-- See-Mode Technologies[https://www.see-mode.com/ ], a MedTech startup based in Singapore and Australia that seeks to empower clinicians to better predict stroke, today announced that it has received two more regulatory approvals – the CE Mark and T...

  Seegene develops world first COVID-19 variant test capable of ... - 01 February 2021 16:53

SEOUL, South Korea, Feb. 1, 2021 /PRNewswire-AsiaNet/ -- - SEEGENE ROLLS OUT FIRST COVID-19 MUTANT IDENTIFICATION TEST - COVID-19 TEST MANUFACTURER CONTINUES TRACKING VARIANTS - S. KOREAN FIRM COMMITTED TO WORKING WITH GOVERNMENTS South Korea's biotechnology firm Seegene (KQ096530) said Monday i...